Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  European Journal of Pharmacology

• Publication date

  1985-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(85)90058-5PMID 3920056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of protein kinase C in cell surface signal transduction and tumour promotion

  1984cited by this paper
• Factors Influencing the Deaggregation of Human and Rabbit Platelets

  1983cited by this paper
• The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).

  1983cited by this paper
• Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin.

  1983cited by this paper
• Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway.

  1983cited by this paper
• Verapamil and Collagen-Induced Platelet Reactions- Evidence for a Role for Intracellular Calcium in Platelet Activation

  1983cited by this paper
• Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells

  1983cited by this paper
• Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets

  1983cited by this paper
• Ca2+ and protein kinase C: Two synergistic cellular signals

  1983cited by this paper
• Inhibition of rabbit platelet aggregation by the Ca2+-antagonists verapamil and diltiazem and by trifluoperazine

  1983cited by this paper
• Phospholipid-induced human platelet activation: effects of calcium channel blockers and calcium chelators.

  1983cited by this paper
• A role of calcium-activated, phospholipid-dependent protein kinase in platelet-activating factor-induced serotonin release from rabbit platelets.

  1982cited by this paper
• Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca‐independent activation for shape‐change and secretion

  1982cited by this paper
• Inhibition of human platelet function by verapamil.

  1982cited by this paper
• Requirements for different Ca2+ pools in the activation of rabbit platelets. I. release reaction and protein phosphorylation.

  1982cited by this paper
• Requirement for different Ca2+ pools in the activation of rabbit platelets II. Phospholipase activity.

  1982cited by this paper
• BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)

  1981cited by this paper
• Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence.

  1981cited by this paper
• Purification and characterization of smooth muscle myosin light chain kinase.

  1981cited by this paper
• Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.

  1981cited by this paper
• 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets.

  1981cited by this paper
• Present concepts on the mechanisms of platelet aggregation.

  1981cited by this paper
• Inhibition of Human Platelet Functions by Verapamil

  1981cited by this paper
• Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction.

  1980cited by this paper
• Platelet‐Activating Factor (PAF‐Acether) Secretion from Platelets: Effect of Aggregating Agents

  1980cited by this paper
• The effect of prostacyclin on platelet aggregation and disaggregation in vivo.

  1980cited by this paper
• The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.

  1980cited by this paper
• The involvement of calcium in epinephrine or ADP potentiation of human platelet aggregation.

  1980cited by this paper
• Possible involvement of Ca2+-activated, phospholipid-dependent protein kinase in platelet activation.

  1980cited by this paper
• Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl choline

  1980cited by this paper
• Phospholipid turnover as a possible transmembrane signal for protein phosphorylation during human platelet activation by thrombin.

  1980cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs.

  1979cited by this paper
• Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

  1979cited by this paper
• Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity.

  1979cited by this paper
• The Role of Myosin Phosphorylation in Regulating Actin-Myosin Interaction in Human Blood Platelets

  1978cited by this paper
• Reversal of platelet aggregation by prostacyclin.

  1978cited by this paper
• Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors.

  1978cited by this paper
• Thrombin-Stimulated Myosin Phosphorylation in Intact Platelets and its Possible Involvement Secretion

  1977cited by this paper
• Structural analysis of purified platelet-activating factor by lipases

  1977cited by this paper
• Inhibition of platelet secretion by an antagonist of intracellular calcium.

  1976cited by this paper
• Platelet 5-HT uptake and release stopped rapidly by formaldehyde

  1975cited by this paper
• Letter to the editors-in-chief: Absence of a requirement for extracellular calcium for secretion from platelets.

  1975cited by this paper
• Excitation‐Contraction Coupling in Rabbit Aorta Studied by the Lanthanum Method for Measuring Cellular Calcium Influx

  1972cited by this paper
• Influence of Apyrase on Stability of Suspensions of Washed Rabbit Platelets

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Adenosine Diphosphate‐induced Platelet Aggregation in Suspensions of Washed Rabbit Platelets

  1970cited by this paper
• Calcium Exchange Diffusion in a Porous Phospholipid Ion-exchange Membrane

  1969cited by this paper
• Calcium Exchange Diffusion in a Porous Phospholipid Ion-exchange Membrane

  1969cited by this paper
• A Theory of Passive Ion Flux through Axon Membranes

  1964cited by this paper

• Platelet Activating Factor and Platelets

  1999cites this paper
• Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.

  1998cites this paper
• Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.

  1998cites this paper
• Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.

  1997cites this paper
• Desaggregation by Verapamil, Sodium Nitroprusside and PGE(1), of Rabbit Platelets Aggregated by PAF-acether. A Morphological and Biochemical Study.

  1993cites this paper
• Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications.

  1990cites this paper
• Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets.

  1990cites this paper
• Effects of PAF and PAF antagonists on the shape of venous endothelial cellsin vitro

  1989cites this paper
• Bay K 8644-induced potentiation of the contractile response of rabbit iliac artery to caffeine in a Ca2+-free medium.

  1989cites this paper
• The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits.

  1989cites this paper
• Effect of Platelet-Activating Factor on Platelets and Vascular Endothelium

  1989cites this paper
• Occult intracellular calcium pools: relevance to neutrophil oxidant production.

  1989cites this paper
• The synthesis, catabolism, and pathophysiological role of platelet-activating factor.

  1989cites this paper
• Natural antagonists of platelet‐activating factor

  1988cites this paper
• [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].

  1988cites this paper
• Effect of verapamil on platelet surface ultrastructure and calcium content.

  1988cites this paper
• Interactions of Ca2+ antagonists at 5-HT2 and H2 receptors and GABA uptake sites

  1987cites this paper
• [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].

  1987cites this paper
• Secretion and properties of a polypeptide factor generated by phorbol ester stimulation of human blood platelets.

  1987cites this paper
• Activated leukocytes and the hemostatic system.

  1987cites this paper
• Certain membrane-interacting amphiphiles inhibit aggregation and reverse shape change of rabbit platelets pre-activated with arachidonic acid through dissociation of cytoskeletal assembly.

  1987cites this paper
• [Action of calcium antagonists on thrombocyte aggregation].

  1987cites this paper
• Influence of anti-platelet drugs on platelet-vessel wall interactions.

  1987cites this paper
• Double Action of Nicardipine on Serotonin Release from Rat Platelets

  1987cites this paper
• Perspectives in platelet-activating factor research.

  1987cites this paper
• Influence of anti-platelet drugs on platelet-vessel waif interacticnks

  1987cites this paper
• Conformational Properties of the PAF-Acether Receptor on Platelets Based on Structure—Activity Studies

  1987cites this paper
• Platelet-Activating Factor: Mechanisms of Cellular Activation

  1987cites this paper
• Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.

  1986cites this paper
• Calcium antagonism and calcium entry blockade.

  1986cites this paper
• LG 30435, a new bronchodilator/antiallergic agent, inhibits PAF-acether induced platelet aggregation and bronchoconstriction

  1986cites this paper
• Possible relationship between the syntheses of endothelium-derived relaxing factor (EDRF) and PAF-acether.

  1986cites this paper
• Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.

  1986cites this paper
• Synergistic effect of PGE1 and the calcium antagonist verapamil in disaggregation of aggregated platelets and inhibition of platelet aggregation induced by PAF-acether or arachidonic acid

  1986cites this paper